345 related articles for article (PubMed ID: 26882989)
1. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
[TBL] [Abstract][Full Text] [Related]
2. Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats.
Zhang Y; Wan J; Xu Z; Hua T; Sun Q
J Cell Physiol; 2019 May; 234(5):7467-7474. PubMed ID: 30367484
[TBL] [Abstract][Full Text] [Related]
3. Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke.
Gong J; Li ZZ; Guo S; Zhang XJ; Zhang P; Zhao GN; Gao L; Zhang Y; Zheng A; Zhang XF; Xiang M; Li H
Hypertension; 2015 Sep; 66(3):604-16. PubMed ID: 26269654
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.
Chen Z; Shen H; Sun C; Yin L; Tang F; Zheng P; Liu Y; Brink R; Rui L
Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E460-9. PubMed ID: 25628422
[TBL] [Abstract][Full Text] [Related]
5. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Xiang M; Wang PX; Wang AB; Zhang XJ; Zhang Y; Zhang P; Mei FH; Chen MH; Li H
J Hepatol; 2016 Jun; 64(6):1365-77. PubMed ID: 26860405
[TBL] [Abstract][Full Text] [Related]
6. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Wu YK; Hu LF; Lou DS; Wang BC; Tan J
Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
[TBL] [Abstract][Full Text] [Related]
7. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
Hu J; Zhu XH; Zhang XJ; Wang PX; Zhang R; Zhang P; Zhao GN; Gao L; Zhang XF; Tian S; Li H
J Hepatol; 2016 Jan; 64(1):146-59. PubMed ID: 26334576
[TBL] [Abstract][Full Text] [Related]
8. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
[TBL] [Abstract][Full Text] [Related]
10. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
12. TAK1 regulates hepatic lipid homeostasis through SREBP.
Morioka S; Sai K; Omori E; Ikeda Y; Matsumoto K; Ninomiya-Tsuji J
Oncogene; 2016 Jul; 35(29):3829-38. PubMed ID: 26973245
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
[TBL] [Abstract][Full Text] [Related]
14. DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.
Xie L; Wang PX; Zhang P; Zhang XJ; Zhao GN; Wang A; Guo J; Zhu X; Zhang Q; Li H
J Hepatol; 2016 Jul; 65(1):113-124. PubMed ID: 27016281
[TBL] [Abstract][Full Text] [Related]
15. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
16. iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway.
Xu M; Ge C; Zhu L; Qin Y; Du C; Lou D; Li Q; Hu L; Sun Y; Dai X; Xiong M; Long T; Zhan J; Kuang Q; Li H; Yang Q; Huang P; Teng X; Feng J; Wu Y; Dong W; Wang B; Tan J
Hepatology; 2021 Apr; 73(4):1346-1364. PubMed ID: 32592194
[TBL] [Abstract][Full Text] [Related]
17. TRAF3 mediates neuronal apoptosis in early brain injury following subarachnoid hemorrhage via targeting TAK1-dependent MAPKs and NF-κB pathways.
Zhou Y; Tao T; Liu G; Gao X; Gao Y; Zhuang Z; Lu Y; Wang H; Li W; Wu L; Zhang D; Hang C
Cell Death Dis; 2021 Jan; 12(1):10. PubMed ID: 33414375
[TBL] [Abstract][Full Text] [Related]
18. Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Wang XA; Zhang R; She ZG; Zhang XF; Jiang DS; Wang T; Gao L; Deng W; Zhang SM; Zhu LH; Guo S; Chen K; Zhang XD; Liu DP; Li H
Hepatology; 2014 Mar; 59(3):870-85. PubMed ID: 24123166
[TBL] [Abstract][Full Text] [Related]
19. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice.
Yu CJ; Wang QS; Wu MM; Song BL; Liang C; Lou J; Tang LL; Yu XD; Niu N; Yang X; Zhang BL; Qu Y; Liu Y; Dong ZC; Zhang ZR
Hepatology; 2018 Nov; 68(5):1769-1785. PubMed ID: 29704259
[TBL] [Abstract][Full Text] [Related]
20. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
